Baseline demographic and clinical characteristics of the study cohort
| Variables | |
|---|---|
| Age, years | 49 ± 10.2 |
| Gender | |
| Female | 16.7% |
| Male | 83.3% |
| BCLC stage | |
| A | 37.5% |
| B | 45.8% |
| C | 16.7% |
| HBsAg positive | 95.8% |
| Serum AFP, ng/dL | |
| < 10 | 29.1% |
| > 10 | 70.9% |
| Average tumor size, cm | 5.4 |